91 related articles for article (PubMed ID: 12749246)
1. Insulin resistance in patients with steatohepatitis.
Saglam K; Kiliç R; Yilmaz MI; Gulec M; Baykal Y; Kutlu M
Hepatogastroenterology; 2003; 50(50):456-9. PubMed ID: 12749246
[TBL] [Abstract][Full Text] [Related]
2. Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non-alcoholic fatty liver disease.
Gulsen M; Yesilova Z; Bagci S; Uygun A; Ozcan A; Ercin CN; Erdil A; Sanisoglu SY; Cakir E; Ates Y; Erbil MK; Karaeren N; Dagalp K
J Gastroenterol Hepatol; 2005 Sep; 20(9):1448-55. PubMed ID: 16105135
[TBL] [Abstract][Full Text] [Related]
3. Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non-alcoholic steatohepatitis.
Sajjad A; Mottershead M; Syn WK; Jones R; Smith S; Nwokolo CU
Aliment Pharmacol Ther; 2005 Aug; 22(4):291-9. PubMed ID: 16097995
[TBL] [Abstract][Full Text] [Related]
4. The association of dehydroepiandrosterone, obesity, waist-hip ratio and insulin resistance with fatty liver in postmenopausal women--a hyperinsulinemic euglycemic insulin clamp study.
Saruç M; Yüceyar H; Ayhan S; Türkel N; Tuzcuoglu I; Can M
Hepatogastroenterology; 2003; 50(51):771-4. PubMed ID: 12828082
[TBL] [Abstract][Full Text] [Related]
5. Metabolic and anthropometric evaluation of insulin resistance in nondiabetic patients with nonalcoholic steatohepatitis.
Chalasani N; Deeg MA; Persohn S; Crabb DW
Am J Gastroenterol; 2003 Aug; 98(8):1849-55. PubMed ID: 12907343
[TBL] [Abstract][Full Text] [Related]
6. The DGAT2 gene is a candidate for the dissociation between fatty liver and insulin resistance in humans.
Kantartzis K; Machicao F; Machann J; Schick F; Fritsche A; Häring HU; Stefan N
Clin Sci (Lond); 2009 Mar; 116(6):531-7. PubMed ID: 18980578
[TBL] [Abstract][Full Text] [Related]
7. Molecular determinants of insulin resistance, cell apoptosis and lipid accumulation in non-alcoholic steatohepatitis.
Piro S; Spadaro L; Russello M; Spampinato D; Oliveri CE; Vasquez E; Benigno R; Brancato F; Purrello F; Rabuazzo AM
Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):545-52. PubMed ID: 18063353
[TBL] [Abstract][Full Text] [Related]
8. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
Kotronen A; Juurinen L; Tiikkainen M; Vehkavaara S; Yki-Järvinen H
Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
[TBL] [Abstract][Full Text] [Related]
9. Distinguishing nonalcoholic steatohepatitis from fatty liver: serum-free fatty acids, insulin resistance, and serum lipoproteins.
Bookman ID; Pham J; Guindi M; Heathcote EJ
Liver Int; 2006 Jun; 26(5):566-71. PubMed ID: 16762001
[TBL] [Abstract][Full Text] [Related]
10. [Application of extended hyperinsulinemic euglycemic clamp in the assessment of insulin sensitivity in obese individuals with glucose intolerance].
Bao YQ; Jia WP; Chen L; Lu JX; Zhu M; Lu W; Xiang KA
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Dec; 28(6):740-4. PubMed ID: 17260458
[TBL] [Abstract][Full Text] [Related]
11. Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance.
Baranova A; Gowder SJ; Schlauch K; Elariny H; Collantes R; Afendy A; Ong JP; Goodman Z; Chandhoke V; Younossi ZM
Obes Surg; 2006 Sep; 16(9):1118-25. PubMed ID: 16989692
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of non-alcoholic steatohepatitis: human data.
Edmison J; McCullough AJ
Clin Liver Dis; 2007 Feb; 11(1):75-104, ix. PubMed ID: 17544973
[TBL] [Abstract][Full Text] [Related]
13. Nutritional aspects in patients with non-alcoholic steatohepatitis (NASH).
Capristo E; Miele L; Forgione A; Vero V; Farnetti S; Mingrone G; Greco AV; Gasbarrini G; Grieco A
Eur Rev Med Pharmacol Sci; 2005; 9(5):265-8. PubMed ID: 16231587
[TBL] [Abstract][Full Text] [Related]
14. The effect of 6 months supplementation with conjugated linoleic acid on insulin resistance in overweight and obese.
Syvertsen C; Halse J; Høivik HO; Gaullier JM; Nurminiemi M; Kristiansen K; Einerhand A; O'Shea M; Gudmundsen O
Int J Obes (Lond); 2007 Jul; 31(7):1148-54. PubMed ID: 17031391
[TBL] [Abstract][Full Text] [Related]
15. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study.
Huang MA; Greenson JK; Chao C; Anderson L; Peterman D; Jacobson J; Emick D; Lok AS; Conjeevaram HS
Am J Gastroenterol; 2005 May; 100(5):1072-81. PubMed ID: 15842581
[TBL] [Abstract][Full Text] [Related]
16. [Role of mitochondrial dysfunction in non-alcoholic steatohepatitis].
Elloumi H; Arfaoui D; Nabli N; Ajmi S
Tunis Med; 2003 Oct; 81(10):763-7. PubMed ID: 17722791
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum GGT concentrations predict reduced insulin sensitivity and increased intrahepatic lipids.
Thamer C; Tschritter O; Haap M; Shirkavand F; Machann J; Fritsche A; Schick F; Häring H; Stumvoll M
Horm Metab Res; 2005 Apr; 37(4):246-51. PubMed ID: 15952086
[TBL] [Abstract][Full Text] [Related]
18. Significant non-alcoholic fatty liver disease is found in non-diabetic, pre-obese Chinese in Singapore.
Chow WC; Tai ES; Lian SC; Tan CK; Sng I; Ng HS
Singapore Med J; 2007 Aug; 48(8):752-7. PubMed ID: 17657385
[TBL] [Abstract][Full Text] [Related]
19. Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis.
Idilman R; Mizrak D; Corapcioglu D; Bektas M; Doganay B; Sayki M; Coban S; Erden E; Soykan I; Emral R; Uysal AR; Ozden A
Aliment Pharmacol Ther; 2008 Jul; 28(2):200-8. PubMed ID: 18445142
[TBL] [Abstract][Full Text] [Related]
20. Fertile females with nonalcoholic fatty liver disease (NAFLD) have higher levels of ALT than postmenopausal females: implications for the influence of fertility on NAFLD.
Kotoh K; Nakamuta M; Fukushima M; Morizono S; Enjoji M; Nawata H
Hepatogastroenterology; 2007; 54(73):224-8. PubMed ID: 17419265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
